Abstract. We aimed to investigate the expression of suppressors cytokine signaling (SOCS)-3, transforming growth factor (TGF)-β and indoleamine 2,3-dioxygense (IDO) and to analyse the relationship of SOCS3 and TGF-β with IDO expression in early pregnancy chorionic villi and decidua in the maternal-fetal interface. Western blot analysis and immunohistochemical method were used to detect the expression of TGF-β, SOCS3 and IDO in chorionic villi and decidua tissues of normal pregnant women. SOCS3, TGF-β and IDO protein was identified in chorionic villi and decidua tissues of normal pregnant women and there was a negative correlation between the expression of IDO and SOCS3, but TGF-β expression was positively correlated with IDO expression. The levels of IDO expression in the decidua from normal pregnancies were significantly higher than those in chorionic villi, while the expression of SOCS3 was no significant difference between decidua and chorionic villi. In normal physiological state of pregnancy, SOCS3 and TGF-β may be involved in the regulation of immune tolerance by positive or negative regulation of IDO expression at maternal fetal interface.
Introduction
It is still not fully understood how a fetus escapes from being attacked by the maternal immune system. Previous studies have suggested that the enzyme indoleamine 2,3-dioxygenase (IDO) is a key protein in the maintenance of maternal-fetal tolerance. During pregnancy, IDO is secreted by placental trophoblast, decidual cells and maternal monocyte-macrophages, which inhibit the T-lymphocyte reaction and mediate the immune tolerance to the fetus via tryptophan depletion and defective tryptophan catabolism (1) . Recent studies have mainly focused on the expression and function of IDO. Here, we studied the relationship of suppressor of cytokine signaling (SOCS)-3 and transforming growth factor (TGF)-β with IDO expression in chorionic villi and decidua during pregnancy to investigate the possibility that the two proteins may regulate the expression of IDO at the maternal-fetal interface.
SOCS3 is part of a protein family that binds cytokine receptors, thereby suppressing cytokine signaling. SOCS3 is an essential regulator of leukemia inhibitory factor receptor signaling in trophoblast differentiation. The expression of SOCS3 is decreased in the placentas of women with intrahepatic cholestasis, demonstrating its essential role in placental development (2, 3) .
TGF-β is abundantly expressed in the endometrium, epithelial glands and trophoblasts. It plays an important role in endometrial inflammatory events associated with menstruation and repair in preparation for implantation, particularly in promoting the decidualization of endometrial stroma, the maternal support of embryo development, immunomodulation at the maternal-fetal interface and the maintenance of normal pregnancy. TGF-β deficiency can lead to miscarriage or fetal death (4, 5) .
Studies have shown that, when cells were transfected with IDO, SOCS3 can downregulate the expression of IDO, while the expression of IDO can be upregulated in cultured dendritic cells or plasmacytoid dendritic cells (pDCs) to which TGF-β had been added (6) . Since IDO, SOCS3 and TGF-β are expressed at the maternal-fetal interface, the aim of this study was to analyze the expression and possible correlation of the three proteins in chorionic villi and decidua. no. GTX100118; GeneTex, Inc., Irvine, CA, USA) for 3.5 h at room temperature, then rinsed with tris-buffered saline with Tween-20 and incubated with secondary horseradish peroxidase (HRP)-labeled goat anti-rabbit immunoglobulin G antibody (PerkinElmer, Inc.). Protein bands were visualized by using the ECL kit followed by autoradiography.
Materials and methods

Ethics
To determine whether SOCS3 and TGF-β expression were related to that of IDO, equal amounts of cell lysate extracted from chorionic villi and decidua were transferred to PVDF membrane (PerkinElmer, Inc.) and then checked with IDO polyclonal antibody (1:1,500), following which the membrane was washed with stripping buffer (Beyotime Institute of Biotechnology) and incubated with SOCS3, TGF-β or GAPDH primary antibody (1:500).
Immunohistochemistry. Tissue specimens were embedded in paraffin wax and each sample continuously sliced into 5 µm sections. After dewaxing and rehydration, slides were immersed in ethylenediaminetetraacetic acid solution and boiled in an electric pressure cooker (3 min) for antigen retrieval. Cooling was performed at room temperature and endogenous peroxidase activity was quenched with 3% hydrogen peroxide (H 2 O 2 ). Sections were washed with 0.1 MPBS (pH 7.4) between each step of the immunostaining process. The primary antibody (mouse anti-human IDO, SOCS3, and TGF-β monoclonal antibody; cat. nos. ab55305, ab14939 and ab64715, respectively; Abcam, Cambridge, UK) were diluted with antibody dilution buffer (Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China) before use (dilution concentration of IDO, SOCS3 and TGF-β antibody was 1:200, 1:120 and 1:200, respectively) then incubated overnight at 4˚C. Sections were then incubated with rabbit anti-mouse HRP antibody (1:1,000; cat. no. K5007; Dako; Agilent Technologies, Inc., Santa Clara, CA, USA) for 30 min at 37˚C. After being washed three times with PBS (pH 7.4), 3,3'-diaminobenzidine (DAB) solution from a DAB kit (Dako; Agilent Technologies, Inc.) was used as the chromogen. Slides were counterstained with hematoxylin and dehydrated. Thereafter, sections were mounted with coverslips. Immunohistochemical images were evaluated using an Olympus microscope (Olympus, Tokyo, Japan). The scores of immunohistochemical images were defined as -, +, ++ or +++ if 0-9, 10-24, 25-50 or >50% of the cells were stained positively, respectively. Immunostaining was scored blindly by two independent observers with experience in immunohistochemical pathology.
Statistical analysis. All statistical analyses were performed using the SPSS statistical software package, version 13 
Results
Analysis of IDO, SOCS3 and TGF-β expression in chorionic villi and decidua by western blot analysis.
To detect the expression of IDO, SOCS3 and TGF-β in chorionic villi and decidua of women in early pregnancy, equal amounts of cell lysates were loaded onto an SDS-PAGE gel, followed by western blot analysis with IDO, SOCS3 and TGF-β polyclonal antibodies or rabbit anti-GAPDH polyclonal antibody. The results showed that, in human peripheral blood mononuclear cells (PBMC), negative control, no protein bands of IDO were found ( Fig. 1) and that IDO, SOCS3 and TGF-β were expressed in chorionic villi ( Figs. 2A-4A ) and decidua (Figs. 2B-4B ). Expression of IDO was stronger in the decidua than in chorionic villi (Fig. 2C, P= 0.005) . No significant difference in SOCS3 expression was observed between chorionic villi and decidua (Fig. 3C, P=0.993) , while similar amounts of GAPDH were detected.
In examining whether SOCS3 and TGF-β expression were related to that of IDO, we found that the expression of SOCS3 and IDO were statistically negatively correlated (chorionic villi, r=-0.808, P=0.004; decidua, r=-0.841, P=0.005), while that of TGF-β and IDO were positively correlated (chorionic villi, r= 0.690, P= 0.039; decidua, r= 0.952, P<0.05) (Figs. 5 and 6 ).
Analysis of IDO, SOCS3 and TGF-β expression in chorionic villi and decidua by immunohistochemistry.
Immunocytochemical staining demonstrated that IDO, SOCS3 and TGF-β are expressed in chorionic villi and decidua. Results of immunohistochemistry were examined at x400 and H&E staining results were examined at x100 magnification. Several representative photomicrographs are shown in Fig. 7 . Based on a semiquantitative scoring system, the expression of IDO and SOCS3 were negatively correlated (Table I) , but there was a positive correlation between IDO and TGF-β (Table II) .
Discussion
Studies have found that IDO-dependent depletion of L-tryptophan decreases the number of cytotoxic T-cells, natural killer (NK) cells and tryptophan metabolites. In particular, the tryptophan metabolite kynurenine is subsequently involved in the inhibition of T and NK cells, inducing the generation of regulatory T(Treg) cells, changing the immune microenvironment in vivo and directly regulating the immune response (7, 8) . Our results indicate that the increased expression of IDO in chorionic villi and decidua may downregulate the immune response mediated by local T-cells, which could prevent the rejection of the fetus by the maternal immune response. Therefore, the factors that regulate IDO protein levels in terms of mediating maternal-fetal tolerance at this site are worthy of further investigation. Moreover, Hönig et al (9) and Kudo et al (10) have reported that IDO is expressed in the chorionic villi and decidua of normal human pregnancies, while IDO protein and mRNA expression in chorionic villi and decidua have been detected by immunohistochemical and PCR methods (11) . Although different technical methods were used, the results of our study are consistent with these previous studies. Increasing evidence suggests that IDO is expressed in endothelial cells and in syncytiotrophoblasts of early or late placental tissues and that IDO is highly expressed in invasive extravillous trophoblast cells in close contact with the maternal immune system (9) . Here, we have used western blot analysis and immunohistochemical methods to confirm that the expression of IDO in human decidua is stronger than that in human chorionic villi, which is in keeping with the above previous studies.
Our results show that SOCS3 is present in chorionic villi and decidua and that there is no significant difference in the expression of this protein between the two tissues. Previous studies have indicated that SOCS3 is involved in trophoblast differentiation and the formation of the placenta, that SOCS3-deficient placentas have decreased spongiotrophoblasts and increased trophoblast secondary giant cells and that SOCS3 negatively regulates trophoblast giant cell differentiation. In addition, SOCS3 regulates the development of the placenta by negatively affecting receptor signaling of leukemia inhibitory factor (2, 12) .
Studies have demonstrated that SOCS3 is able to downregulate the expression of IDO in mouse unfractionated dendritic cells transfected with IDO. The reason for the downregulation may be that the IDO molecule contains two immunoreceptor tyrosine-based inhibitory motifs (13, 14) with different molecular chaperone binding, either to promote the degradation of IDO, or to activate its signaling activity and maintain the original enzyme activity (15) . If SOCS3 anchors in the phosphorylated ITIM of IDO, IDO is bound to the E3 ubiquitin enzyme complex and degraded (16, 17) . If the ITIM on IDO molecules combines with tyrosine phosphatase, the expression of IDO protein is enhanced. Our previous study demonstrates that the negative correlation of expression between SOCS3 and IDO exists in the chorionic villi and decidua of women in early pregnancy, and reveals the possibility that SOCS3 may participate in immune regulation via the degradation of IDO at the maternal-fetal interface. It is tempting to speculate that the degradation of IDO may be a new function of SOCS3 in human chorionic villi and decidua. However, whether or not SOCS3 can degrade IDO at the maternal-fetal interface requires further study. Although the expression of SOCS3 and IDO is negatively correlated, the expression of SOCS3 and IDO coexist. To some extent, IDO remains stably expressed in human chorionic villi and decidua, suggesting that other factors may be involved in regulating and maintaining stable expression of IDO.
TGF-β transmits signals via the Smad and mitogenactivated protein kinase signaling pathways, which regulate the proliferation, differentiation and invasion of trophoblast cells (18) and promote the process of endometrial decidualization. In this study, western blot analysis and immunohistochemistry were used to detect the expression of TGF-β protein in human chorionic villi and decidua of early gestation and the results were consistent with that of previous studies (19) . Studies have shown that TGF-β induces immunotolerance by inhibiting B lymphocytes (20) , downregulating major histocompatibility complex antigen expression in target cells (5, 21) and amplifying T-cells in vivo and in vitro. Fallarino et al and Pallotta et al (6, 22) found that TGF-β could upregulate IDO expression in vitro cultured cells. IDO gene silencing technology can abolish increased expression of IDO by TGF-β. In contrast, 1-methyl tryptophan, as an IDO inhibitor, cannot inhibit the upregulation of induced TGF-β. In 2013, Hanks et al (23) also demonstrated that the expression of IDO was upregulated by TGF-β in the tumor microenvironment in animals. Further studies have found that TGF-β is able to phosphorylate the ITIM of IDO and induce its upregulation. Our results show that the expression of IDO concomitantly increases as the expression of TGF-β increases and that the expression of TGF-β and IDO is positively correlated, hinting that TGF-β may be involved in maintaining immune tolerance by upregulating IDO expression at the maternal-fetal interface.
In conclusion, our study demonstrates that IDO, SOCS3 and TGF-β are expressed in chorionic villi and decidua, where IDO expression is negatively correlated with SOCS3 and positively correlated with TGF-β. This suggests a possible role for SOCS3 and TGF-β in maintaining immunotolerance by regulating IDO expression at the maternal-fetal interface. Further investigation is needed to elucidate the mechanisms behind the regulation of IDO expression by SOCS3 and TGF-β. Table I . Immunohistochemical staining for IDO and SOCS3 in chorionic villi and decidua from normal pregnancies. The results from linear-by-linear association are 6.031, which shows that there is a linear trend between IDO and SOCS3. The correlation coefficient calculated by Spearman's correlation is -0.511 (P= 0.011), further explaining that they are negatively correlated. Table II . Immunohistochemical staining for IDO and TGF-β in chorionic villi and decidua from normal pregnancies. The results from linear-by-linear association are 6.264, which shows that there is a linear trend between IDO and TGF-β. The correlation coefficient calculated by Spearman's correlation is 0.474 (P=0.019), further explaining that they are negatively correlated.
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